HCV elimination unlikely to be hindered by suboptimal direct-acting antiviral efficacy

The efficacy of direct-acting antivirals in people with HIV and hepatitis C virus originating from Sub-Saharan Africa and southeastern Asia but living in Europe is high, according to a recent study published in Open Forum Infectious Diseases.
The researchers added that this means hepatitis C elimination for this population in Europe is unlikely to be hampered by suboptimal direct-acting antiviral (DAA) efficacy.
“In high-income countries, hepatitis C virus (HCV) was mainly spread in the second half of the 20th century. Therefore, the genetic diversity of HCV in these countries is

The efficacy of direct-acting antivirals in people with HIV and hepatitis C virus originating from Sub-Saharan Africa and southeastern Asia but living in Europe is high, according to a recent study published in Open Forum Infectious Diseases.
The researchers added that this means hepatitis C elimination for this population in Europe is unlikely to be hampered by suboptimal direct-acting antiviral (DAA) efficacy.
“In high-income countries, hepatitis C virus (HCV) was mainly spread in the second half of the 20th century. Therefore, the genetic diversity of HCV in these countries is